The Tokyo District Court sentenced a 65-year-old man to a two-year prison term Thursday for administering lymphocyte to cancer patients without having a doctor’s license — a violation of the Medical Practitioners Law and Pharmaceutical Affairs Law.
In handing down the decision, Judge Kaoru Kanayama said Hironari Suzuki, president of CBS Research Institute, damaged public trust in the medical practice and took advantage of patients’ hopes for recovery.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see this support page.
We humbly apologize for the inconvenience.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.
SUBSCRIBE NOW
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.